These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 21056696

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
    Hlavaty T, Pierik M, Henckaerts L, Ferrante M, Joossens S, van Schuerbeek N, Noman M, Rutgeerts P, Vermeire S.
    Aliment Pharmacol Ther; 2005 Oct 01; 22(7):613-26. PubMed ID: 16181301
    [Abstract] [Full Text] [Related]

  • 23. Treatment of fistulizing Crohn's disease.
    Judge TA, Lichtenstein GR.
    Gastroenterol Clin North Am; 2004 Jun 01; 33(2):421-54, xi-xii. PubMed ID: 15177547
    [Abstract] [Full Text] [Related]

  • 24. Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn's fistulas.
    Ng SC, Plamondon S, Gupta A, Burling D, Kamm MA.
    Aliment Pharmacol Ther; 2009 Oct 01; 30(7):757-66. PubMed ID: 19575762
    [Abstract] [Full Text] [Related]

  • 25. Infliximab serum concentrations and disease activity in perianal fistulizing Crohn's disease: a cross-sectional study.
    Miranda EF, Nones RB, Baraúna FB, de Nardi Marçal G, Olandoski M, de Moraes TP, Kotze PG.
    Tech Coloproctol; 2024 Jul 20; 28(1):86. PubMed ID: 39031218
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Faecal diversion in the management of perianal Crohn's disease.
    Hong MK, Craig Lynch A, Bell S, Woods RJ, Keck JO, Johnston MJ, Heriot AG.
    Colorectal Dis; 2011 Feb 20; 13(2):171-6. PubMed ID: 19863597
    [Abstract] [Full Text] [Related]

  • 28. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas.
    Tozer P, Ng SC, Siddiqui MR, Plamondon S, Burling D, Gupta A, Swatton A, Tripoli S, Vaizey CJ, Kamm MA, Phillips R, Hart A.
    Inflamm Bowel Dis; 2012 Oct 20; 18(10):1825-34. PubMed ID: 22223472
    [Abstract] [Full Text] [Related]

  • 29. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.
    Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P.
    Gut; 2009 Apr 20; 58(4):492-500. PubMed ID: 18832518
    [Abstract] [Full Text] [Related]

  • 30. Review article: The medical treatment of Crohn's perianal fistulas.
    Schwartz DA, Herdman CR.
    Aliment Pharmacol Ther; 2004 May 01; 19(9):953-67. PubMed ID: 15113362
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated?
    Domènech E, Hinojosa J, Nos P, Garcia-Planella E, Cabré E, Bernal I, Gassull MA.
    Aliment Pharmacol Ther; 2005 Dec 01; 22(11-12):1107-13. PubMed ID: 16305724
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
    Bor R, Farkas K, Bálint A, Szucs M, Ábrahám S, Baradnay G, Wittmann T, Szepes Z, Nagy F, Molnár T.
    Scand J Gastroenterol; 2015 Feb 01; 50(2):182-7. PubMed ID: 25384713
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Indications and results of infliximab in Crohn's disease].
    Karoui S, Boubaker J, Filali A.
    Tunis Med; 2004 Dec 01; 82(12):1057-63. PubMed ID: 15822505
    [Abstract] [Full Text] [Related]

  • 36. Infliximab treatment and prognostic factors for response in patients with Crohn's disease.
    Mendoza JL, García-Paredes J, Cruz Santamaria DM, Lana R, Ramírez Fernández E, Rodríguez Asteaga E, Díaz-Rubio M.
    Rev Esp Enferm Dig; 2002 May 01; 94(5):269-79. PubMed ID: 12474335
    [Abstract] [Full Text] [Related]

  • 37. Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapy.
    Papamichael K, Cheifetz AS.
    World J Gastroenterol; 2017 Sep 14; 23(34):6197-6200. PubMed ID: 28974885
    [Abstract] [Full Text] [Related]

  • 38. Infliximab in the surgical management of complex fistulating anal Crohn's disease.
    Talbot C, Sagar PM, Johnston MJ, Finan PJ, Burke D.
    Colorectal Dis; 2005 Mar 14; 7(2):164-8. PubMed ID: 15720356
    [Abstract] [Full Text] [Related]

  • 39. [Treatment of Crohn's disease by infliximab. About 20 cases].
    Serghini M, Karoui S, Meknini M, Matri S, Kallel L, Fekih M, Boubaker J, Filali A.
    Tunis Med; 2009 Sep 14; 87(9):579-82. PubMed ID: 20180377
    [Abstract] [Full Text] [Related]

  • 40. [The use of adalimumab in severe fistulising Crohn's disease].
    Bang UC, Nielsen AM.
    Ugeskr Laeger; 2008 Jun 16; 170(25):2256. PubMed ID: 18565318
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.